In this section, you'll find news releases from RSNA 2021 exhibitors. The releases are listed in chronological order and are archived by month and year.
Bracco’s attendance at RSNA follows FDA approval of Gadopiclenol injection, a novel macrocyclic high-relaxivity gadolinium-based contrast agent which will be commercialized as VUEWAYTM (gadopiclenol) injection by Braccoi, ii
This groundbreaking breast imaging technology helps clinicians confidently characterize breast masses, potentially saving patients time, money, and anxiety
The category-defining Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology.